IRIS
CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.776
EU - Europa 4.205
AS - Asia 2.850
SA - Sud America 497
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 12.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.719
CN - Cina 1.197
IE - Irlanda 1.090
SG - Singapore 859
UA - Ucraina 773
SE - Svezia 569
IT - Italia 518
BR - Brasile 432
RU - Federazione Russa 334
HK - Hong Kong 283
DE - Germania 230
FR - Francia 192
FI - Finlandia 189
TR - Turchia 169
IN - India 133
GB - Regno Unito 132
VN - Vietnam 100
BE - Belgio 53
CA - Canada 32
CZ - Repubblica Ceca 30
AR - Argentina 19
BD - Bangladesh 16
EC - Ecuador 14
MX - Messico 14
RO - Romania 13
IR - Iran 12
PL - Polonia 12
ES - Italia 11
IQ - Iraq 11
EU - Europa 10
ID - Indonesia 10
NL - Olanda 10
JO - Giordania 9
ZA - Sudafrica 9
CO - Colombia 8
GR - Grecia 8
RS - Serbia 8
UZ - Uzbekistan 8
AT - Austria 7
JP - Giappone 7
LT - Lituania 7
MA - Marocco 7
PY - Paraguay 7
PK - Pakistan 6
TN - Tunisia 6
CL - Cile 5
PT - Portogallo 5
SA - Arabia Saudita 5
TH - Thailandia 5
VE - Venezuela 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
PE - Perù 4
AU - Australia 3
CI - Costa d'Avorio 3
DZ - Algeria 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
CH - Svizzera 2
HR - Croazia 2
KE - Kenya 2
MT - Malta 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
CD - Congo 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
SD - Sudan 1
SN - Senegal 1
UG - Uganda 1
Totale 12.381
Salva come PNG Salva come JPEG
Città #
Dublin 1.090
Chandler 588
Jacksonville 540
Dearborn 455
Dallas 431
Singapore 395
Ashburn 360
Nyköping 331
Hong Kong 280
Nanjing 278
Beijing 208
Wilmington 175
Santa Clara 152
Munich 146
Princeton 122
Nanchang 102
San Mateo 102
Ann Arbor 99
Helsinki 80
New York 73
Woodbridge 72
Shenyang 70
Boardman 67
Des Moines 64
The Dalles 63
Foggia 54
Moscow 53
Brussels 51
Jiaxing 46
Hebei 43
Tianjin 43
Kunming 41
Bari 40
Dong Ket 38
Los Angeles 37
Guangzhou 30
Pune 29
London 28
Rome 28
Seattle 28
Changsha 26
Ho Chi Minh City 26
Jinan 25
São Paulo 24
Hangzhou 21
Brooklyn 20
Milan 20
Brno 19
Council Bluffs 19
Shanghai 18
Auburn Hills 17
Hanoi 17
Ningbo 15
Changchun 14
Rio de Janeiro 14
Augusta 13
Stevenage 13
Toronto 13
Turku 13
Zhengzhou 13
Boston 12
Washington 12
Hilden 11
Olomouc 11
San Francisco 11
Stockholm 11
Taizhou 11
West Jordan 11
Belo Horizonte 10
Bologna 10
Chicago 10
Phoenix 10
Hefei 9
Lanzhou 9
Porto Alegre 9
Shenzhen 9
Warsaw 9
Manchester 8
Orange 8
Philadelphia 8
Sorocaba 8
Curitiba 7
Dhaka 7
Florence 7
Istanbul 7
Lucera 7
Mumbai 7
Redwood City 7
Tashkent 7
Timisoara 7
Amman 6
Atlanta 6
Brasília 6
Campinas 6
Columbus 6
Falkenstein 6
Frankfurt am Main 6
Guayaquil 6
Leawood 6
Ardabil 5
Totale 7.621
Salva come PNG Salva come JPEG
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 721
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica/leucotrienica 208
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab 194
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia crociata a fico e gelsi 159
Allergy to artichoke: a case report. 138
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 137
"Metodo diagnostico in vitro per allergia respiratoria da polline di Cupressus arizonica". 137
Terapia con Omalizumab nell'asma severo persistente: presentazione di un caso clinico 134
Fusaproliferin production by Fusarium subglutinans and toxicity to Artemia salina, SF-9 insect cells and IARC/LCL 171 human B-lymphocytes. 132
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet 132
5-lipoxygenase upregulation by dexamethasone in human mast cells. 129
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells. 123
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia al carciofo 122
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 122
Terapia con Omalizumab: valutazione di efficacia e tollerabilità in una casistica di 21 soggetti con asma severo non controllato 121
Allergia alimentare da finocchio (Phoeniculum Vulgare) ed altre Apiaceae 121
Flaws and improvement in skin testing in Hymenoptera venom allergy. 118
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evedence for a noncopetitive mode of action 118
Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 118
General adverse reaction to aspirin administered by transdermal iontophoresis. 116
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. 116
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili. 115
Sviluppo ed applicazione di una procedura di monitoring dell'asma persistente basato su registrazione di sintomi e PEF 115
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 114
Olive pollen allergy in Bari, Italy. 113
Allergeni alimentari emergenti della dieta mediterranea 112
Cyclooxygenase-2 expression in oral squamous cell carcinoma 111
Development and application of an improved sympton score and PEF card-based procedure in the management of persistent asthma 110
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components. 110
Grape anaphylaxis 108
Five-lipoxygenase/leukotreiene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-infiammatory properties. 108
Beauvericin cytotoxicity to the invertebrate cell line SF-9. 107
Characteristics and treatment regimens across ERS SHARP severe asthma registries 106
EFFETTI DEL MONTELUKAST SULLA BIOSINTESI DEI LEUCOTRIENI E SULL'ATTIVITA' ENZIMATICA DELLA 5-LO 106
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet. 106
Airborne Cupressaceae pollen in Southern Italy 105
Changes in skin reactivity, specific IgE and IgG levels after 1 year of immunotherapy in olive pollinosis. 104
Allergy to pomegranate and artichoke, novel food allergens of the mediterranean diet. 104
Significativo declino dei valori di IgE specifiche legate, evidenziato da skin prick tests quantitativi, in pazienti con asma severo trattati con omalizumab 104
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 102
Nuove acquisizioni sul meccanismo di azione dei corticosteroidi. 102
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 102
Allergia alimentare da finocchio (Phoeniculum vulgare) ed altre Apiaceae 102
Wasp immunotherapy induces a long term and IgG4-independent protection. 102
A new subcutaneous protocol for persistent desensitisation to Rituximab. 101
Omalizumab in severe allergic asthma: efficacy assessment by comparison of pre- and post-therapy symptom score and peak espiratory flow (PEF) values. 100
Monitoring of atmospheric conditions and forecast of olive pollen season. 100
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 100
Novel inibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 98
Flaws and improvements in skin testing in hymenoptera venom allergy 98
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 98
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: PRESENTAZIONE DI UN CASO CLINICO 97
Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma. 96
Purification and fine characterization of the major allergen from Olea europaea pollen extract. 96
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: VALUTAZIONE DI EFFICACIA E TOLLERABILITA' IN UNA CASISTICA DI TRENTA PAZIENTI 96
Fig and mulberry cross-allergy 95
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties. 94
Retrospective monitoring in the management of persistent asthma 94
Skin testing technique and precision in stinging insect allergy 93
Italian real-life experience of omalizumab. 93
Fennel (Foeniculum vulgare); a major allergen of the Mediterranean diet 93
Skin testing technique and precision in stinging insect allergy 92
Management dell'anafilassi da alimenti 91
Omalizumab e monitoraggio retrospettivo dei sintomi e del PEF nell'asma severo non controllato 90
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 89
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. 88
Punti di debolezza ed ottimizzazione dei tests cutanei nell'allergia a veleno di imenotteri 88
Desensitization in Iron Product Allergy 88
Novel food allergens of the Mediterranean diet. 87
Tako-Tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 86
Indirect food contact in severe fish allergy. 85
Omalizumab and retrospective syntom score and PEF monitoring in severe asthma 85
L'orticaria (da un punto di vista allergologico) 85
Impact of Omalizumab in 21 patients with severe asthma 84
Food Allergy in Southern Italy. Allergy to cynara scolymus 83
Leukotriene biosyntesis inhibition and direct 5-lipoxygenase non competitive inhibition by the Cys-LT1 receptor antagonists montelukast ans zafirlukast. 83
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) noncompetitive inhibition by the cys-LT1 receptor antagonist montelukast. 83
Terapia dell'asma severo con anticorpo monoclonale anti-IgE. Significativo declino dei valori di IgE specifiche legate, evidenziato da Skin Prick Tests Quantitativi. 83
Efficacia e tollerabilità di Omalizumab (Xolair) dopo due anni di trattamento: studio in 17 soggetti con asma severo 83
Systemic adverse reaction to diclofenac administered by transdermal iontophoresis. 82
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 82
Immunological characterization of onion (Allium cepa) allergy 82
Cost-effectiveness of grass pollen allergen immunotherapy in adults 82
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak espiratory flow values before and after therapy. J Investig Allergol Clin Immunol; 81
Fennel (Foeniculum vulgare) allergy. Nico A, Vacca M, Bellotti A, Di Giacomo M, Giliberti A, Lotti A, Caiaffa MF, Macchia L. 81
Italian real-life experience of omalizumab 80
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 80
Tests cutanei nel monitoraggio dell'immunoterapia a veleno di imenotteri 79
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 78
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 78
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 77
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 77
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 76
Studi "in vivo" sulla cross-reattività allergenica tra polline di Compositae anemofile e Compositae edibili 75
The lymphocyte proliferation test (LTP) in the diagnosis of critical cases of delayed drug allergy. 75
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 74
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 74
Purification and fine characterization of the major allergen from Olea Europaea pollen extract. 73
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and Cypress pollen 73
Omalizumab in long-term treatment of refractory chronic spontaneous urticaria: effects of discontinuation. 72
Totale 10.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 0 0 66 149 71 172 162 12 50
2021/2022715 102 1 7 23 62 21 26 53 98 70 33 219
2022/20232.690 242 114 121 161 148 247 47 203 1.249 39 59 60
2023/2024620 78 19 28 17 58 227 16 68 1 15 12 81
2024/20252.271 108 15 124 74 75 307 240 183 565 174 195 211
2025/20261.745 223 301 594 453 161 13 0 0 0 0 0 0
Totale 12.633